Boxlight Corp

This management proposal requests shareholder approval to amend the Articles of Incorporation to increase authorized Class A common shares from 4,166,667 to 55,000,000 (and increase total authorized shares accordingly). Management frames the request as necessary because a December 2025 1-for-6 reverse split reduced authorized shares to a level that constrains the Company’s ability to issue shares for conversions, warrant exercises, equity awards and future capital raises. The Company reports reserved shares and outstanding instruments that would require additional authorized shares, and it says shareholder approval is needed to preserve flexibility to raise capital to refinance debt, satisfy preferred stock redemptions, fund working capital and continue equity-based compensation. The board also acknowledges that the amendment could be dilutive and may have potential anti-takeover effects but emphasizes there would be no immediate change to outstanding shares or holder rights absent further issuances. Management intends to file the amendment promptly if approved and highlights that the text of the amendment appears in Annex A to the proxy. The board recommends a FOR vote because inadequate authorized shares could materially limit the Company’s ability to address near-term liquidity needs and to implement compensation and financing transactions. Given the company’s disclosed liquidity pressures and active instruments (warrants, preferred stock), approval materially expands financing optionality but increases potential dilution risk to existing holders. Shareholders should weigh the immediate need for capital flexibility against dilution and governance considerations, including anti-takeover implications. The proposal is presented as routine under Nasdaq rules, allowing broker votes, but abstentions or broker non-votes could effectively count against it if classified as non-routine.

This management proposal seeks shareholder pre-approval under Nasdaq Rule 5635(d) to issue shares (or convertibles) equal to 20% or more of outstanding Class A stock in non-public transactions, principally to permit an equity line of credit (ELOC) of up to $15 million. The proposed ELOC would allow the Company to draw at its discretion over a 24-month term, with shares priced at up to a 5% VWAP discount, a potential commitment fee up to 5%, investor ownership capped at 9.99%, registration on Form S-1, and no variable-rate debt features. Management frames this as critical to address near-term liquidity pressures—without additional capital the company states there is substantial doubt about its ability to continue as a going concern—and to support commercialization of its Symphony product line. The proposal includes explicit limits on aggregate shares (20,833,334 shares), dollar amount ($15 million), maximum discount (5%), and timing (initially three months post-approval, potentially extendable to six months with Nasdaq approval). The board emphasizes that pre-approval will allow the Company to move quickly to pursue financing opportunities while remaining Nasdaq-compliant, and unanimously recommends a FOR vote. The approval would enable rapid capital access but carries dilution risk to existing shareholders and potential concentration of ownership; issuance could also have anti-takeover effects by allowing the Company to dilute a bidder’s stake. The terms (VWAP discount, commitment fees, registration) mitigate some marketability concerns but will likely be evaluated by investors against dilution, timing, and the Company’s disclosed going-concern risks. The proposal balances immediate liquidity needs and commercialization funding against dilution and governance trade-offs; sophisticated investors should evaluate investor protections, exact formula mechanics, and potential impact on share float and control.